Acquisition

Born from a Novartis mega-deal, Atrium Therapeutics aims its novel RNA platform at rare, untreatable genetic heart diseases. Will its strategy succeed?

The Kansas City firm was named to the inaugural Skift M&I 15 list, a recognition fueled by key acquisitions and its pioneering AI-powered JOY Index.

Deal activity is surging in private markets, but a new era of selective investment and AI-driven opportunities is forcing investors to adapt. Here's the outlook.

Kitchen equipment maker Li Bang International is acquiring a major caterer, a bold move to nearly double its revenue and dive into China's booming food service market.

The acquisition aims to bridge the gap between city hall paperwork and public works, creating a single, integrated system for managing modern municipalities.

With over $450M in new assets, Concurrent’s growth highlights a major industry shift as RIAs trade old-school freedom for platform-powered independence.

Former FHA Commissioner Brian Montgomery's move to NewDay USA signals a strategic play to deepen its service to veterans in a complex housing market.

Dycom Industries will detail its role in the digital revolution at key investor conferences, backed by record earnings and a major data center acquisition.

Scientific Beta co-founder Marc Zieger's move to QuantumStreet AI signals a major shift as AI fintechs aim to dominate institutional investing.

In a cautious market, local firm Regional Group acquires a landmark tower, signaling strong confidence in the resilience of premium downtown office space.

A new technology bypasses device makers to give networks unprecedented control of location data, promising to power a new economy of 'Physical AI'.

Global giant Odevo acquires Seacrest and PBM, adding 58,000 units and signaling a tech-fueled consolidation push in Florida's hot property market.

IoT specialist KORE Group agrees to a take-private acquisition by Searchlight and Abry, offering a massive 691% premium to shareholders.

As Summit Midstream sets its Q4 earnings date, all eyes are on whether recent acquisitions and strong gas trends can solidify its financial recovery.

Fulgent Genetics reports revenue growth but faces a pivotal year with a major customer loss, betting its future on strategic acquisitions and a promising drug pipeline.

Gogo's revenue doubled to $910M in 2025 after a major acquisition, but a Q4 loss and new tech rollout put its bold global strategy to the test.

A new lawsuit from a rival CEO puts Jura Energy's Pakistani assets in the crosshairs, escalating a feud rooted in a multi-million dollar arbitration.

Treace Medical reports a Q4 revenue dip despite surgeon growth, revealing a strategic shift to lower-priced kits and a challenging 2026 outlook.

As BCE's CEO prepares for a key investor conference, the telecom giant balances a bold AI growth strategy against concerns over near-term profitability.

Endeavour Silver saw record 2025 revenue from new mines but posted a $119M loss due to financial instruments, high costs, and rising security risks in Mexico.